MGNX - MacroGenics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MGNX is currently covered by 11 analysts with an average price target of $8.17. This is a potential upside of $6.58 (413.84%) from yesterday's end of day stock price of $1.59.

MacroGenics's activity chart (see below) currently has 123 price targets and 124 ratings on display. The stock rating distribution of MGNX is 50% HOLD and 50% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 51.31% with an average time for these price targets to be met of 198.13 days.

Highest price target for MGNX is $14, Lowest price target is $2, average price target is $5.8.

Most recent stock forecast was given by STEPHEN WILLEY from STIFEL on 14-May-2025. First documented stock forecast 12-Nov-2014.

Currently out of the existing stock ratings of MGNX, 20 are a HOLD (50%), 20 are a BUY (50%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$5

$3.42 (216.46%)

$6

5 days ago
(14-May-2025)

3/12 (25%)

$3.45 (222.58%)

135

Buy

$3

$1.42 (89.87%)

$8

5 days ago
(14-May-2025)

3/10 (30%)

$1.45 (93.55%)

445

Hold

$2

$0.42 (26.58%)

$4

1 months 24 days ago
(25-Mar-2025)

13/16 (81.25%)

$0.21 (11.73%)

187

Hold

$8

6 months 12 days ago
(07-Nov-2024)

4/9 (44.44%)

$4.24 (112.77%)

203

Buy

$14

$12.42 (786.08%)

$7

9 months 4 days ago
(15-Aug-2024)

9/11 (81.82%)

$10.74 (329.45%)

159

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MGNX (MacroGenics) average time for price targets to be met?

On average it took 198.13 days on average for the stock forecasts to be realized with a an average price target met ratio 51.31

Which analyst has the current highest performing score on MGNX (MacroGenics) with a proven track record?

THOMAS SHRADER

Which analyst has the most public recommendations on MGNX (MacroGenics)?

Thomas Shrader works at BTIG and has 10 price targets and 9 ratings on MGNX

Which analyst is the currently most bullish on MGNX (MacroGenics)?

Christopher Marai with highest potential upside - $45.34

Which analyst is the currently most reserved on MGNX (MacroGenics)?

Silvan Tuerkcan with lowest potential downside - -$0

MacroGenics in the News

MacroGenics to Participate in Upcoming Investor Conference

ROCKVILLE, MD, May 01, 2025 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative antibody-based therapeutics for the treatment of cancer, today announced that members of the Company’s management team will participate in the following investor conference this month: The Citizens Life Sciences Conference (New York)....

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?